Paris, France

Carole Neves




Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Carole Neves: Innovator in Pharmaceutical Applications

Introduction

Carole Neves is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of chemokine receptor antagonists. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

One of her latest patents involves solid forms of a chemokine receptor antagonist and methods of use thereof. This patent discloses the citrate salt of (S)-4-(4-Chloro-phenyl)-1-{3-[7-(1-hydroxy-1-methyl-ethyl)-11H-10-oxa-1-aza-dibenzo[a,d]cyclohepten-5-ylidene]-propyl}-3,3-dimethyl-piperidin-4-ol, which may be utilized in pharmaceutical applications. The patent discusses the crystalline citrate salt, including specific single crystal forms and combinations of these forms. It also covers mixtures for forming the crystalline salts, methods of producing the citrate salt, and using such forms in treating diseases associated with aberrant leukocyte recruitment, activation, or both.

Career Highlights

Throughout her career, Carole Neves has worked with notable companies in the pharmaceutical industry, including Aventis Pharma S.A. and Millennium Pharmaceuticals Limited. Her expertise in the field has allowed her to make significant advancements in drug development.

Collaborations

Carole has collaborated with esteemed colleagues such as Pascal Billot and Jacques Bourget. These partnerships have contributed to her innovative work and the successful development of her patents.

Conclusion

Carole Neves is a distinguished inventor whose work in pharmaceutical applications has the potential to transform treatment options for various diseases. Her contributions to the field are noteworthy and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…